David Schairer

Title(s)Assistant Clinical Professor, Dermatology
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. A multimodal initiative improves general pediatric provider management of atopic dermatitis in children: A prospective interventional study. J Am Acad Dermatol. 2023 Nov; 89(5):1041-1044. Lee SS, Kaushik A, Natsis N, Kusari A, Schairer D, Lindback S, Levenberg M, Mills JR, Peeples K, Smith R, Eichenfield LF. PMID: 37516950.
      View in: PubMed   Mentions:    Fields:    
    2. Acute paronychia in a neonate secondary to clindamycin-resistant Staphylococcus aureus. Pediatr Dermatol. 2022 Nov; 39(6):985-986. Osmani S, Schairer DO. PMID: 36047838.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    3. Atopic Dermatitis: New Developments. Dermatol Clin. 2019 Jan; 37(1):11-20. Kusari A, Han AM, Schairer D, Eichenfield LF. PMID: 30466683.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansPHPublic Health
    4. Nanoparticle-Encapsulated Doxorubicin Demonstrates Superior Tumor Cell Kill in Triple Negative Breast Cancer Subtypes Intrinsically Resistant to Doxorubicin. Precis Nanomed. 2018 Oct; 1(3):173-182. Krausz AE, Adler BL, Makdisi J, Schairer D, Rosen J, Landriscina A, Navati M, Alfieri A, Friedman JM, Nosanchuk JD, Rodriguez-Gabin A, Ye KQ, McDaid HM, Friedman AJ. PMID: 31032494; PMCID: PMC6483385.
      View in: PubMed   Mentions: 4  
    5. Safety and efficacy of topical cantharidin for the treatment of pediatric molluscum contagiosum: a prospective, randomized, double-blind, placebo-controlled pilot trial. Int J Dermatol. 2018 Aug; 57(8):1001-1006. Guzman AK, Schairer DO, Garelik JL, Cohen SR. PMID: 29904968.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    6. Emerging therapies for atopic dermatitis: JAK inhibitors. J Am Acad Dermatol. 2018 03; 78(3 Suppl 1):S53-S62. Cotter DG, Schairer D, Eichenfield L. PMID: 29248518.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansAnimals
    7. Severe contact dermatitis due to ethylenediamine dihydrochloride in nystatin cream. J Allergy Clin Immunol Pract. 2017 Sep - Oct; 5(5):1448-1450. Iammatteo M, Akenroye A, Jariwala S, Lee B, Schairer D, Rosenstreich D. PMID: 28396110.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    8. TWEAK/Fn14 Signaling Involvement in the Pathogenesis of Cutaneous Disease in the MRL/lpr Model of Spontaneous Lupus. J Invest Dermatol. 2015 Aug; 135(8):1986-1995. Doerner JL, Wen J, Xia Y, Paz KB, Schairer D, Wu L, Chalmers SA, Izmirly P, Michaelson JS, Burkly LC, Friedman AJ, Putterman C. PMID: 25826425; PMCID: PMC4504782.
      View in: PubMed   Mentions: 30     Fields:    Translation:AnimalsCells
    9. Fidgetin-Like 2: A Microtubule-Based Regulator of Wound Healing. J Invest Dermatol. 2015 Sep; 135(9):2309-2318. Charafeddine RA, Makdisi J, Schairer D, O'Rourke BP, Diaz-Valencia JD, Chouake J, Kutner A, Krausz A, Adler B, Nacharaju P, Liang H, Mukherjee S, Friedman JM, Friedman A, Nosanchuk JD, Sharp DJ. PMID: 25756798; PMCID: PMC4537388.
      View in: PubMed   Mentions: 27     Fields:    Translation:AnimalsCells
    10. Evaluation of the antibiotic properties of glutathione. J Drugs Dermatol. 2013 Nov; 12(11):1272-7. Schairer DO, Chouake JS, Kutner AJ, Makdisi J, Nosanchuk JD, Friedman AJ. PMID: 24196336.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    11. The impact of sexual dysfunction on health-related quality of life in people with multiple sclerosis. Mult Scler. 2014 Apr; 20(5):610-6. Schairer LC, Foley FW, Zemon V, Tyry T, Campagnolo D, Marrie RA, Gromisch ES, Schairer D. PMID: 23999609.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    12. Amphotericin B releasing nanoparticle topical treatment of Candida spp. in the setting of a burn wound. Nanomedicine. 2014 Jan; 10(1):269-77. Sanchez DA, Schairer D, Tuckman-Vernon C, Chouake J, Kutner A, Makdisi J, Friedman JM, Nosanchuk JD, Friedman AJ. PMID: 23770066.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansAnimals
    13. Cantharidin therapy: practice patterns and attitudes of health care providers. J Am Acad Dermatol. 2013 Jun; 68(6):1045-6. Pompei DT, Rezzadeh KS, Viola KV, Lee DH, Schairer DO, Chismar LA, Cohen SR. PMID: 23680201.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    14. Nitrosoglutathione generating nitric oxide nanoparticles as an improved strategy for combating Pseudomonas aeruginosa-infected wounds. J Drugs Dermatol. 2012 Dec; 11(12):1471-7. Chouake J, Schairer D, Kutner A, Sanchez DA, Makdisi J, Blecher-Paz K, Nacharaju P, Tuckman-Vernon C, Gialanella P, Friedman JM, Nosanchuk JD, Friedman AJ. PMID: 23377518.
      View in: PubMed   Mentions: 9     Fields:    Translation:AnimalsCells
    15. Antimicrobial and anti-inflammatory activity of chitosan-alginate nanoparticles: a targeted therapy for cutaneous pathogens. J Invest Dermatol. 2013 May; 133(5):1231-9. Friedman AJ, Phan J, Schairer DO, Champer J, Qin M, Pirouz A, Blecher-Paz K, Oren A, Liu PT, Modlin RL, Kim J. PMID: 23190896; PMCID: PMC3631294.
      View in: PubMed   Mentions: 65     Fields:    Translation:HumansCells
    16. The potential of nitric oxide releasing therapies as antimicrobial agents. Virulence. 2012 May 01; 3(3):271-9. Schairer DO, Chouake JS, Nosanchuk JD, Friedman AJ. PMID: 22546899; PMCID: PMC3442839.
      View in: PubMed   Mentions: 152     Fields:    
    17. Psychology and psychiatry in the dermatologist's office: an approach to delusions of parasitosis. J Drugs Dermatol. 2012 Apr; 11(4):543-5. Schairer D, Schairer L, Friedman A. PMID: 22453598.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    18. Nitric oxide-releasing nanoparticles accelerate wound healing in NOD-SCID mice. Nanomedicine. 2012 Nov; 8(8):1364-71. Blecher K, Martinez LR, Tuckman-Vernon C, Nacharaju P, Schairer D, Chouake J, Friedman JM, Alfieri A, Guha C, Nosanchuk JD, Friedman AJ. PMID: 22406184.
      View in: PubMed   Mentions: 29     Fields:    Translation:Animals
    19. Nitric oxide nanoparticles: pre-clinical utility as a therapeutic for intramuscular abscesses. Virulence. 2012 Jan-Feb; 3(1):62-7. Schairer D, Martinez LR, Blecher K, Chouake J, Nacharaju P, Gialanella P, Friedman JM, Nosanchuk JD, Friedman A. PMID: 22286699; PMCID: PMC3337151.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansAnimalsCells
    20. Manifestations and treatment of cutaneous lupus erythematosus (Part II of II). J Drugs Dermatol. 2011 Dec; 10(12):1474-6. Schairer D, Friedman A. PMID: 22134575.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    21. Letter to the editor--atrial fibrillation: an inflammatory and autoimmune disorder. Heart Rhythm. 2012 Feb; 9(2):e2; author reply e2-3. Schairer DO, Levis WR. PMID: 22100332.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    22. Manifestations and treatment of cutaneous lupus erythematosus (part I of II). J Drugs Dermatol. 2011 Oct; 10(10):1212-4. Schairer D, Friedman A. PMID: 21968677.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    23. Improved antimicrobial efficacy with nitric oxide releasing nanoparticle generated S-nitrosoglutathione. Nitric Oxide. 2011 Nov 30; 25(4):381-6. Friedman AJ, Blecher K, Schairer D, Tuckman-Vernon C, Nacharaju P, Sanchez D, Gialanella P, Martinez LR, Friedman JM, Nosanchuk JD. PMID: 21946032.
      View in: PubMed   Mentions: 18     Fields:    Translation:Cells